Tag Archive: Gaucher disease

May 02

FDA Approves New Orphan Drug (Elelyso) to Treat Gaucher Disease

On May 1, 2012, the U.S. Food and Drug Administration (“FDA”) approved a new orphan drug to treat Gaucher disease. The drug, Elelyso (taliglucerase alfa), is an injection therapy used for enzyme replacement in people with the rare genetic disorder.  Gaucher disease is essentially an enzyme deficiency that causes the buildup of lipids in several …

Continue reading »

Switch to our mobile site